UBC Medical Indonesia Tbk. vs Sari Kreasi Boga Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Sari Kreasi Boga Tbk. trades at Rp36 (market cap 115.74B, 1.83M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6× Sari Kreasi Boga Tbk.'s market cap, and Sari Kreasi Boga Tbk. is more actively traded (1.83M versus 635.5K). Which is the better fit depends on your goals.
| LABS | RAFI | |
|---|---|---|
Market Cap | 691.25B | 115.74B |
Volume | 635.5K | 1.83M |
Lot | 6.36K | 18.26K |
Turnover | 110.15M | — |
Average Price | 173.33 | — |
Value | 110.15M | — |
Indicative Equilibrium Price | 174 | — |
Indicative Equilibrium Volume | 50 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Sari Kreasi Boga Tbk (the Company) was established based on Deed No. 29 dated July 17, 2017 made before Notary Mahendra Adinegara, S.H., M.Kn. in Jakarta.
Read more on RAFI →